"Aged" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.
Descriptor ID |
D000368
|
MeSH Number(s) |
M01.060.116.100
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged".
Below are MeSH descriptors whose meaning is more specific than "Aged".
This graph shows the total number of publications written about "Aged" by people in this website by year, and whether "Aged" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 303 | 303 |
1995 | 2 | 390 | 392 |
1996 | 0 | 355 | 355 |
1997 | 2 | 382 | 384 |
1998 | 2 | 439 | 441 |
1999 | 0 | 452 | 452 |
2000 | 1 | 502 | 503 |
2001 | 0 | 503 | 503 |
2002 | 2 | 578 | 580 |
2003 | 1 | 921 | 922 |
2004 | 1 | 972 | 973 |
2005 | 0 | 1034 | 1034 |
2006 | 0 | 1106 | 1106 |
2007 | 1 | 1077 | 1078 |
2008 | 2 | 1154 | 1156 |
2009 | 1 | 1197 | 1198 |
2010 | 0 | 1357 | 1357 |
2011 | 1 | 1508 | 1509 |
2012 | 0 | 1503 | 1503 |
2013 | 1 | 1651 | 1652 |
2014 | 0 | 1591 | 1591 |
2015 | 0 | 1681 | 1681 |
2016 | 0 | 1590 | 1590 |
2017 | 0 | 1858 | 1858 |
2018 | 0 | 1722 | 1722 |
2019 | 0 | 1670 | 1670 |
2020 | 0 | 1558 | 1558 |
2021 | 0 | 1250 | 1250 |
2022 | 0 | 453 | 453 |
2023 | 0 | 374 | 374 |
2024 | 0 | 58 | 58 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged" by people in Profiles.
-
Improved Symptom Change Enhances Quality of Dying in Patients With Advanced Cancer: An East Asian Cross-Cultural Study. Oncologist. 2024 Apr 04; 29(4):e553-e560.
-
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clin Cancer Res. 2024 Apr 01; 30(7):1273-1280.
-
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults. JAMA Netw Open. 2024 Apr 01; 7(4):e244954.
-
Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper. Clin Infect Dis. 2024 03 20; 78(3):505-513.
-
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy. Am J Hematol. 2024 May; 99(5):880-889.
-
An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders. CNS Drugs. 2024 Apr; 38(4):239-254.
-
An Umbrella Review of Self-Management Interventions for Health Conditions With Symptom Overlap With Traumatic Brain Injury. J Head Trauma Rehabil. 2024 Mar-Apr 01; 39(2):140-151.
-
Impact of COVID-19-related experiences on health-related quality of life in cancer survivors in the United States. PLoS One. 2024; 19(3):e0297077.
-
Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation. Blood Adv. 2024 Mar 12; 8(5):1128-1136.
-
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial. Lancet. 2024 Mar 23; 403(10432):1153-1163.